ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 242

Clinical and Laboratory Features of IgG4-Related Retroperitoneal Fibrosis/Periarteritis in Japan: Retrospective Multicenter Study of 99 Cases

Ichiro Mizushima1, Satomi Kasashima2, Motohisa Yamamoto3, Takako Saeki4, Kazunori Yamada5, Dai Inoue6, Fuminori Kasashima7, Yasushi Matsumoto7, Eisuke Amiya8, Kenji Notohara9, Yasuharu Sato10, Yoh Zen11, Shigeyuki Kawa12, Mitsuhiro Kawano1 and Nobukazu Ishizaka13, 1Division of Rheumatology, Kanazawa University Hospital, Kanazawa, Japan, 2Department of Clinical Laboratory and Pathology, National Hospital Organization, Kanazawa Medical Center, Kanazawa, Japan, 3First Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan, 4Department of Internal Medicine, Nagaoka Red Cross Hospital, Nagaoka, Japan, 5Department of Advanced Research in Community Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan, 6Department of Radiology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan, 7Department of Cardiovascular Surgery, National Hospital Organization, Kanazawa Medical Center, Kanazawa, Japan, 8Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan, 9Department of Pathology, Kurashiki Central Hospital, Kurashiki, Japan, 10Department of Pathology, Okayama University Graduate School of Medicine, Okayama, Japan, 11Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan, 12Center for Health, Safety and Environmental Management, Shinshu University, Matsumoto, Japan, 13Department of Cardiology, Osaka Medical College, Osaka, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Clinical research, diagnosis and immunoglobulin (IG)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Miscellaneous Rheumatic and Inflammatory Diseases - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

<span”>

Background/Purpose:  IgG4-related disease (IgG4-RD) is a recently recognized systemic inflammatory disorder that can affect many organs. It frequently causes retroperitoneal/periarterial lesions, which are referred to as IgG4-related retroperitoneal fibrosis/periarteritis (RF/P). However, clinical and laboratory features of this disease have not been well clarified. This study aimed to clarify the clinical and laboratory features of IgG4-related RF/P. <span”>

Methods: We retrospectively evaluated clinical features including subjective symptoms, laboratory data, and imaging findings at diagnosis in 99 patients (pts) diagnosed with IgG4-related RF/P by experienced physicians. The diagnosis of this disease was made principally on the basis of the presence of consistent retroperitoneal/periarterial radiological findings, the fulfillment of the comprehensive diagnostic criteria or each set of organ-specific diagnostic criteria, and exclusion of other diseases. <span”>

Results: Eighty-four pts were men, and 15 were women (average age 67.4 years). At diagnosis, 42.4% of pts presented subjective symptoms including pain (23.2%), fever (8.1%), and edema (4.1%). Allergic predisposition was found in 37.4% of pts. Hydronephrosis was detected in 21.2%. Current or past smoking was present in 65.4%.<span”>IgG4-related other organ involvement was detected in 69.7%, and the average number of involved other organs was 1.9 (range: 0-8). Serologically, the average serum IgG4 level was 851 mg/dL (range: 59-3610), and 91.8% of pts had serum IgG4 > 135 mg/dL. Hypocomplementemia was observed in 24.4%. An elevated serum C-reactive protein (CRP) level (> 1 mg/dL) was found in 23.6%. The affected aorta/artery comprised mainly 8 thoracic aortas, 67 abdominal aortas, 50 iliac arteries, 8 mesenteric arteries, and 9 coronary arteries. Luminal dilatation of the affected lesions at diagnosis was observed in 26.3% of pts. On the other hand, 24.3% had retroperitoneal, periureteral, or renal pelvic lesions.<span”> Compared with pts without biopsy of the retroperitoneal/periarterial lesions, pts with it showed significantly lower serum IgG4 levels (643 vs 953 mg/dL, P=0.011) and IgG4/IgG ratio (23.9 vs 31.1 %, P=0.022), higher serum IgE (1,533 vs 543 IU/mL, P=0.020) and CRP levels (1.65 vs 0.56 mg/dL, P=0.025), lower incidence of other organ involvement (30.3 vs 86.4 %, P<0.001) and allergy (21.2 vs 45.5 %, P=0.027), and higher incidence of luminal dilatation (42.4 vs 18.2 %, P=0.015), pain (36.4 vs 16.7 %, P=0.043), and current smoking (58.8 vs 26.6 %, P=0.020). Multivariate logistic regression analysis indicated that the presence of other organ involvement [Odds ratio (OR); 0.011, P<0.001], serum CRP elevation (OR; 3.81, P=0.002), and the presence of iliac artery lesion (OR; 0.049, P=0.008) had an independent influence on the performance of biopsies of the retroperitoneal/periarterial lesions.

Conclusion: The present study clarified the clinical and laboratory features of IgG4-related RF/P, and suggested the possibility that biopsy of the retroperitoneal/periarterial lesions was avoidable in pts with other organ involvement.


Disclosure: I. Mizushima, None; S. Kasashima, None; M. Yamamoto, None; T. Saeki, None; K. Yamada, None; D. Inoue, None; F. Kasashima, None; Y. Matsumoto, None; E. Amiya, None; K. Notohara, None; Y. Sato, None; Y. Zen, None; S. Kawa, None; M. Kawano, None; N. Ishizaka, None.

To cite this abstract in AMA style:

Mizushima I, Kasashima S, Yamamoto M, Saeki T, Yamada K, Inoue D, Kasashima F, Matsumoto Y, Amiya E, Notohara K, Sato Y, Zen Y, Kawa S, Kawano M, Ishizaka N. Clinical and Laboratory Features of IgG4-Related Retroperitoneal Fibrosis/Periarteritis in Japan: Retrospective Multicenter Study of 99 Cases [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/clinical-and-laboratory-features-of-igg4-related-retroperitoneal-fibrosisperiarteritis-in-japan-retrospective-multicenter-study-of-99-cases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-and-laboratory-features-of-igg4-related-retroperitoneal-fibrosisperiarteritis-in-japan-retrospective-multicenter-study-of-99-cases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology